Dassault Systèmes SE (DSYA.F)
| Previous close | 35.85 |
| Open | 35.76 |
| Bid | 35.99 x N/A |
| Ask | 36.19 x N/A |
| Day's range | 35.76 - 35.76 |
| 52-week range | 32.60 - 48.70 |
| Volume | |
| Avg. volume | 255 |
| Market cap | 46.763B |
| Beta (5Y monthly) | 0.56 |
| PE ratio (TTM) | 42.07 |
| EPS (TTM) | 0.85 |
| Earnings date | 24 Oct 2024 |
| Forward dividend & yield | 0.23 (0.64%) |
| Ex-dividend date | 27 May 2024 |
| 1y target est | N/A |
Business WireEORTC Extends Medidata Partnership to Help Power New Phase of Oncology Research
LONDON, September 11, 2024--Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, and the European Organisation for Research and Treatment of Cancer (EORTC), announced today a four-year extension to their partnership. The extended relationship will enable EORTC to further increase patient access to oncology clinical trials, make trial participation easier, and help to deliver new treatments to the market faster. EORTC is now leveragin
GlobeNewswireDassault Systèmes: declaration of the number of outstanding shares and voting rights as of August 31, 2024
Press ReleaseVELIZY-VILLACOUBLAY, France — September 5, 2024 Declaration of the number of outstanding shares and voting rights as of August 31, 2024 Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced below the total number of its outstanding shares and voting rights as of August 31, 2024, according to articles 223-16 and 221-3 of the General Regulation of the Autorité des marchés financiers. Number of outstanding shares: 1,339,313,330Number of voting rights*: 2,013,085,275
Business WireAixial Group Migrates Specific Clinical Data Portfolio Onto Medidata Platform to Create a Single Source of Truth and Accelerate Database Lock
LONDON, September 03, 2024--Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced a new project with Aixial Group, a contract research organization (CRO), to streamline the execution of studies and achieve database lock faster. Aixial Group will migrate clinical data from one of its business units onto the Medidata Platform to create a Single Source of Truth (SSOT) that enables study teams to support patient data priva
